Connect

School and Program Updates

School and Program Updates

SUNY Downstate: Appoints Dr. Michael Szarek as New Executive Director of the Center for Clinical and Outcomes Research

Suny Downstate School of Public Health is pleased to announce the appointment of Michael Szarek, PhD, MS, Professor of Epidemiology and Biostatistics, as Executive Director of the Center for Clinical and Outcomes Research effective immediately.  In this role, Dr. Szarek will provide oversight and leadership in the development of academic programs in health economics, outcomes, and market access.  He will also provide leadership in the management and execution of clinical research across SUNY Downstate Health Sciences University.

Dr. Szarek served as chair of the Department of Epidemiology and Biostatistics from 2010 to 2020 and Associate Dean for Research Administration from 2015 to 2020.  He has served as a member of Executive Steering Committees and Data Safety Monitoring Committees for clinical trials of treatments for cardiovascular disease (atorvastatin, torcetrapib, lomitapide, alirocumab, apabetalone, sotagliflozin), complications of COVID-19 infection (colchicine, rivaroxaban, rNAPc2), and cancer (anastrozole, naratuximab emtansine), and as the statistical editor for the Journal of the American College of Cardiology (JACC) and JACC – Cardiovascular Interventions.

Dr. Szarek has been a co-author on several publications in leading scientific journals, including the New England Journal of Medicine, Journal of the American Medical Association, and Cell, and on late-breaking presentations at the American College of Cardiology Scientific Sessions and the American Heart Association Scientific Sessions.  While at Harvard University, he was a Schering Plough Scholar and recipient of a National Cancer Institute (NCI) National Research Service Award training grant.

Dr. Szarek has an MS in Biostatistics from Harvard School of Public Health and a PhD in Biostatistics from New York University. Please join us in congratulating Dr. Szarek.